Expression and characterization of recombinant human micro-plasminogen

[1]  Xiaoxin Li,et al.  Production of Recombinant Human Microplasminogen and Pilot Study in Inducing Posterior Vitreous Detachment , 2005, Current eye research.

[2]  Y. Ni,et al.  Microplasmin Reduces Ischemic Brain Damage and Improves Neurological Function in a Rat Stroke Model Monitored With MRI , 2004, Stroke.

[3]  N. Nagai,et al.  Comparative effects of microplasmin and tissue‐type plasminogen activator (tPA) on cerebral hemorrhage in a middle cerebral artery occlusion model in mice , 2004, Journal of thrombosis and haemostasis : JTH.

[4]  N. Nagai,et al.  Recombinant human microplasmin: production and potential therapeutic properties , 2003, Journal of thrombosis and haemostasis : JTH.

[5]  P. Lapchak,et al.  Microplasmin: A Novel Thrombolytic That Improves Behavioral Outcome After Embolic Strokes in Rabbits , 2002, Stroke.

[6]  Ping Wang,et al.  The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation. , 2002, Biochimica et biophysica acta.

[7]  M. Llinás,et al.  Lysine‐50 is a likely site for anchoring the plasminogen N‐terminal peptide to lysine‐binding kringles , 1998, Protein science : a publication of the Protein Society.

[8]  C. Ponting,et al.  Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide. , 1998, The Biochemical journal.

[9]  A. Horrevoets,et al.  The Activation-resistant Conformation of Recombinant Human Plasminogen Is Stabilized by Basic Residues in the Amino-terminal Hinge Region (*) , 1995, The Journal of Biological Chemistry.

[10]  V. Gurewich,et al.  The kinetics of plasminogen activation by thrombin-cleaved pro-urokinase and promotion of its activity by fibrin fragment E-2 and by tissue plasminogen activator. , 1993, Blood.

[11]  V. Gurewich,et al.  The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation. , 1991, Thrombosis research.

[12]  F. Castellino,et al.  Expression of human plasminogen cDNA in a baculovirus vector-infected insect cell system. , 1989, Archives of biochemistry and biophysics.

[13]  H. Wu,et al.  Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen. , 1988, The Journal of biological chemistry.

[14]  B. Binder,et al.  Plasminogen activation by tissue plasminogen activator in the presence of stimulating CNBr fragment FCB-2 of fibrinogen is a two-phase reaction. Kinetic analysis of the initial phase of slow plasmin formation. , 1988, The Journal of biological chemistry.

[15]  V. Gurewich,et al.  Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained. , 1988, The Journal of clinical investigation.

[16]  S. Peltz,et al.  Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids. , 1982, Biochemistry.

[17]  L. Flohé,et al.  Structural relationship between human high and low molecular mass urokinase. , 1982, Hoppe-Seyler´s Zeitschrift für physiologische Chemie.

[18]  F. Castellino,et al.  [29] Human plasminogen , 1981 .